United States · FDA National Drug Code directory
Zynteglo
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 73554-3111_ad3b5513-b7ff-492d-ad78-ea5a4bd44510
- Product NDC
- 73554-3111
- Form
- SUSPENSION
- Composition / generic term
- betibeglogene autotemcel
- Labeler
- Genetix Biotherapeutics Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20220817
- Source listing expiry
- 20271231
Source-listed ingredients
- BETIBEGLOGENE AUTOTEMCEL — 20000000 1/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SUSPENSION in 1 BAG (73554-3111-1) · 73554-3111-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →